Caliber Wealth Management (Kansas)’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$215K Sell
5,026
-2,802
-36% -$152K 0.02% 282
2026
Q1
$491K Buy
7,828
+476
+6% +$38.1K 0.05% 173
2025
Q4
$701K Buy
7,352
+381
+5% +$37.4K 0.08% 151
2025
Q3
$681K Buy
6,971
+239
+4% +$24.8K 0.08% 153
2025
Q2
$723K Sell
6,732
-77
-1% -$7.79K 0.08% 151
2025
Q1
$687K Buy
+6,809
New +$686K 0.09% 145

Other funds holding BSX

Caliber Wealth Management (Kansas)'s BSX Position: Q2 2026 in Review

Caliber Wealth Management (Kansas) reduced its Boston Scientific (BSX) stake by 36% in Q2 2026, selling an estimated $152K and leaving 5,026 shares worth $215K. The position accounts for 0.02% of the portfolio, ranked #282.

Caliber Wealth Management (Kansas) first reported a position in BSX in Q1 2025 and has held it in 6 quarters since. The position peaked at $723K in Q2 2025. 467 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Caliber Wealth Management (Kansas) held 5,026 shares of Boston Scientific worth $215K as of Q2 2026.
  • Caliber Wealth Management (Kansas) sold 2,802 Boston Scientific shares in Q2 2026, an estimated $152K.
  • Boston Scientific made up 0.02% of Caliber Wealth Management (Kansas)'s portfolio in Q2 2026, its #282 holding.
  • Caliber Wealth Management (Kansas) first reported a position in Boston Scientific in Q1 2025 and has held it in 6 quarters since.
  • Caliber Wealth Management (Kansas)'s Boston Scientific position peaked at $723K in Q2 2025.
  • 467 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Caliber Wealth Management (Kansas)'s 13F filing for Q2 2026, filed 22 Jul 2026.